✦ LIBER ✦
No-Myeloablative Conditioning Regimen Cyclosphophamide-Fludarabine-ATG (Cy-Flu-ATG) Results in Better Overall Survival Compared with Myeloablative Doses of Cy with or without ATG, in High-Risk Bone Marrow Failure Syndromes (BMFS) Patients
✍ Scribed by Abello, Virginina; Villamizar, Licet; Pedraza, Enrique; Esguerra, Herman; Rosales, Carmen; Rosales, Manuel; Figueroa, Javier; Cordoba, Iris; Linares, Adriana
- Book ID
- 122140881
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 49 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.